OLMA
Olema Pharmaceuticals, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +19.3% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 77 | -5 | 48.00M | $600.59M | +5 | −10 |
| Q1 2026 | 85 | +7 | 50.63M | $755.34M | +15 | −8 |
| Q4 2025 | 78 | +3 | 39.80M | $995.19M | +3 | — |
| Q3 2025 | 16 | 0 | 15.07M | $147.57M | +1 | −1 |
| Q2 2025 | 13 | -1 | 13.76M | $58.63M | — | −1 |
| Q1 2025 | 11 | -1 | 8.23M | $30.93M | +1 | −2 |
| Q4 2024 | 12 | 0 | 11.47M | $66.81M | — | — |
| Q3 2024 | 11 | 0 | 7.78M | $92.93M | +1 | −1 |
| Q2 2024 | 11 | — | 6.52M | $70.59M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 3.69M | +14.8% | $44.03M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 1.25M | +847.2% | $14.96M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 1.25M | +847.2% | $14.96M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 1.00M | +10.8% | $11.97M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 1.00M | +10.8% | $11.97M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.00M | +10.8% | $11.97M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.00M | +10.8% | $11.97M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Geode Capital Management ✦ (pasivo) | 934.93K | -11.8% | $11.17M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Geode Capital Management ✦ (pasivo) | 934.93K | -11.8% | $11.17M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 400.00K | +23.1% | $4.78M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Marshall Wace ✦ | 240.39K | -59.2% | $2.87M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 100.05K | -45.1% | $1.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Millennium Management ✦ | 78.06K | Nuevo | $932,036 | 0.0% | New | 1 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 31.46K | +0.7% | $376,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 29.40K | -44.7% | $351,036 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 25.59K | +21.5% | $305,580 | 0.0% | ▲ Add | 2 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Millennium Management | $932,036 | 0.0% |
Posición cerrada
| AQR Capital Management | $131,192 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 200.00K acciones, $10,000 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.